Amphastar Pharmaceuticals publishes second quarter results and holds conference call on August 9, 2021

Rancho Cucamonga, 7/29/2021 / 1:20 PM, PST / PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc.

RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that it will post financial results for the second quarter of 2021 through June 30, 2021 after close on Monday the 9th financial results at 2:00 p.m. Pacific Time.

To join the conference call, dial toll free (877) 407-0989; for international calls, dial (201) 389-0921 five minutes before the conference.

The call can also be found on the investor page on the company’s website at

Amphastar is a specialty pharmaceutical company that primarily develops, manufactures, markets and distributes generic and proprietary injection and inhalation products, including products with high technical barriers to entry. Most of the company’s products are used in hospitals or in emergency care and are primarily commissioned and sold through group purchasing organizations and pharmaceutical wholesalers.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements. These statements are not historical facts but are based on Amphastar’s historical performance and its current expectations, estimates and projections regarding Amphastar’s business, operations and other similar or related factors. Words like “could”, “could”, “will”, “could”, “would”, “should”, “foresee”, “predict”, “potentially”, “further”, “expect”, “intend” Although not all forward-looking statements contain these words, “plan,” “project,” “believe,” “estimate” and other similar or related expressions are used to identify these forward-looking statements These involve known and unknown risks, uncertainties and assumptions that are difficult or impossible to predict and, in some cases, are beyond Amphastar’s control.Actual results could differ materially from those in the forward-looking statements due to a number of factors, including those indicated in the forward-looking statements Described in Amphastar’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for December The year ended 31, 2020, filed with the SEC on March 15, 2021. These reports can be found on the company’s website at and on the SEC’s website at The forward-looking statements in this press release speak only as of the date of publication. Amphastar undertakes no obligation to revise or update any information or forward-looking statements in this press release to reflect future events or circumstances, even as new information becomes available or subsequent events cause Amphastar’s expectations to change.


Bill Peters
(909) 476-3416

SOURCE: Amphastar Pharmaceuticals, Inc.

07/29/2021 EQS Newswire / EQS Group AG

Comments are closed.